Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study

WE Abara, KT Bernstein, FMT Lewis… - The Lancet Infectious …, 2022 - thelancet.com
Background Declining antimicrobial susceptibility to current gonorrhoea antibiotic treatment
and inadequate treatment options have raised the possibility of untreatable gonorrhoea …

[HTML][HTML] Public willingness to receive chlamydia, gonorrhea, syphilis, and trichomoniasis vaccines: a scoping review

T Valleroy, C Garon, J Perroud, AL Wagner - BMC Health Services …, 2023 - Springer
Abstract Background Sexually transmitted infections (STIs) like chlamydia, gonorrhea,
syphilis, and trichomoniasis contribute significantly to global morbidity and mortality …

Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection

D Nikitin, LK Whittles, JW Imai-Eaton… - The Journal of …, 2024 - academic.oup.com
Background Observational evidence suggests the 4CMenB meningococcal vaccine may
partially protect against gonorrhea, with 1 dose being two-thirds as protective as 2 doses …

[HTML][HTML] Engagement With HIV and COVID-19 Prevention: Nationwide Cross-sectional Analysis of Users on a Geosocial Networking App

TW Gaither, JT Sigalos, RJ Landovitz, JN Mills… - Journal of Medical …, 2022 - jmir.org
Background Geosocial networking (GSN) apps play a pivotal role in catalyzing sexual
partnering, especially among men who have sex with men. Objective To quantify the …